In a significant advancement for diabetes management, the new Dexcom G7 continuous glucose monitor...
semaglutide
UPDATE: A groundbreaking study reveals that 50% of adults using the weight-loss drug semaglutide...
Biogen Inc. CEO Chris Viehbacher has indicated that a successful trial of Novo Nordisk...